Behavioral effects of direct- and indirect-acting dopaminergic agonists.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002421:Caudate Nucleus / Q000502:physiology; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006892:Hydroxydopamines / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology*; D051379:Mice; D008954:Models, Biological; D010477:Perfusion; D011956:Receptors, Cell Surface / Q000187:drug effects*; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000378:metabolism; D013238:Stereotaxic Techniques; D013378:Substantia Nigra / Q000502:physiology; D013569:Synapses / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D006892:Hydroxydopamines; D008781:Methyltyrosines; D011956:Receptors, Cell Surface; D014316:Tritium; D014443:Tyrosine; D000661:Amphetamine; D001058:Apomorphine; D004298:Dopamine